+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Med BioGene Inc (MBI.H) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 31 Pages
  • December 2021
  • GlobalData
  • ID: 1367902
Med BioGene Inc (MBI.H) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Med BioGene Inc (Med BioGene) is a life sciences company, which develops and commercializes genome-based clinical laboratory diagnostic tests. It is focused on the development and the commercialization of its 15-gene Signature of GeneFx Lung (formerly LungExpress Dx) which is a proprietary gene expression-based test. Its GeneFx Lung test is used to identify patients with early-stage non-small-cell lung cancer (NSCLC) and determine whether they are at higher or lower risk of mortality following the surgical removal of their tumor. The company has collaboration with University Health Network (UHN). Med BioGene is headquartered in Vancouver, British Columbia, Canada.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Med BioGene Inc - Key Facts
  • Med BioGene Inc - Key Employees
  • Med BioGene Inc - Key Employee Biographies
  • Med BioGene Inc - Major Products and Services
  • Med BioGene Inc - History
  • Med BioGene Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 - Company Analysis
  • Company Overview
  • Med BioGene Inc - Business Description
  • R&D Overview
  • Med BioGene Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Med BioGene Inc - Strengths
  • Med BioGene Inc - Weaknesses
  • Med BioGene Inc - Opportunities
  • Med BioGene Inc - Threats
  • Med BioGene Inc - Key Competitors

Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Med BioGene Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
  • Med BioGene Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
  • Med BioGene Inc, Recent Deals Summary

Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About The Publisher
  • Contact The Publisher
  • Disclaimer

List of Tables
  • Med BioGene Inc, Key Facts
  • Med BioGene Inc, Key Employees
  • Med BioGene Inc, Key Employee Biographies
  • Med BioGene Inc, Major Products and Services
  • Med BioGene Inc, History
  • Med BioGene Inc, Subsidiaries
  • Med BioGene Inc, Key Competitors
  • Med BioGene Inc, Ratios based on current share price
  • Med BioGene Inc, Annual Ratios
  • Med BioGene Inc, Interim Ratios
  • Med BioGene Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
  • Med BioGene Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
  • Med BioGene Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures
  • Med BioGene Inc, Performance Chart (2017 - 2020)
  • Med BioGene Inc, Ratio Charts
  • Med BioGene Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
  • Med BioGene Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021



Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Verisante Technology Inc
  • Takeda Canada Inc
  • StageZero Life Sciences Ltd
  • Oncolytics Biotech Inc
  • Lung Therapeutics Inc